HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E M Veys Selected Research

E M Veys Research Topics

Disease

16Rheumatoid Arthritis
06/2009 - 03/2000
16Spondylarthropathies
04/2005 - 03/2000
11Inflammation (Inflammations)
06/2009 - 03/2000
8Necrosis
06/2009 - 06/2000
7Crohn Disease (Crohn's Disease)
10/2006 - 01/2001
5Ankylosing Spondylitis
05/2003 - 05/2000
4Arthritis (Polyarthritis)
06/2009 - 01/2001
4Psoriatic Arthritis
08/2005 - 01/2001
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2005 - 12/2002
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2006 - 07/2001
2Synovitis
11/2005 - 01/2001
2Ulcerative Colitis
02/2005 - 09/2001
2Rheumatoid Nodule
05/2004 - 03/2000
2Osteoarthritis
05/2004 - 06/2002
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2001 - 03/2000
1Melanoma (Melanoma, Malignant)
06/2009
1Renal Cell Carcinoma (Grawitz Tumor)
06/2009
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2005
1Demyelinating Diseases (Demyelinating Disease)
01/2005
1Alopecia (Baldness)
09/2004
1Hemolytic Anemia
09/2004
1Joint Diseases (Joint Disease)
05/2004
1Retropharyngeal Abscess
09/2003
1Bacterial Infections (Bacterial Infection)
09/2003
1Infections
09/2003
1Tuberculosis (Tuberculoses)
09/2003
1Dermatomyositis (Dermatopolymyositis)
12/2002
1Connective Tissue Diseases (Connective Tissue Disease)
10/2002
1Uveitis
05/2002
1Low Back Pain (Lumbago)
12/2000
1Ulcer
09/2000
1Pain (Aches)
06/2000

Drug/Important Bio-Agent (IBA)

13Infliximab (Remicade)FDA Link
06/2009 - 06/2000
11AntibodiesIBA
02/2006 - 12/2002
8Proteins (Proteins, Gene)FDA Link
06/2009 - 09/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2009 - 01/2001
5CytokinesIBA
06/2009 - 05/2001
4Rheumatoid FactorIBA
09/2005 - 12/2004
4Monoclonal AntibodiesIBA
03/2002 - 03/2000
3Biomarkers (Surrogate Marker)IBA
06/2009 - 10/2002
3Antinuclear AntibodiesIBA
06/2009 - 09/2004
3Etanercept (Enbrel)FDA Link
06/2009 - 01/2001
3Peptides (Polypeptides)IBA
02/2006 - 02/2005
3Biological ProductsIBA
09/2005 - 01/2001
3AutoantibodiesIBA
12/2004 - 10/2001
2InterleukinsIBA
06/2009 - 05/2001
2Anti-Citrullinated Protein AntibodiesIBA
08/2005 - 02/2005
2Scavenger Receptors (Scavenger Receptor)IBA
02/2005 - 04/2001
2Messenger RNA (mRNA)IBA
09/2000 - 03/2000
2CateninsIBA
09/2000 - 03/2000
2Cadherins (E-Cadherin)IBA
09/2000 - 03/2000
1Collagen Type II (Type II Collagen)IBA
06/2009
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
06/2009
1AlginatesIBA
06/2009
1Immunoglobulin M (IgM)IBA
06/2009
1Sorafenib (BAY 43-9006)FDA Link
06/2009
1N 30IBA
06/2009
1Genetic Markers (Genetic Marker)IBA
10/2006
1Nerve Growth Factors (Neurotrophins)IBA
11/2005
1EnzymesIBA
09/2005
1cyclic citrullinated peptideIBA
08/2005
1Complementary DNA (cDNA)IBA
05/2004
1RNA (Ribonucleic Acid)IBA
05/2004
1EpitopesIBA
05/2004
1Immunoglobulin A (IgA)IBA
05/2003
1Cell Adhesion MoleculesIBA
12/2002
1ChondroitinIBA
06/2002
1IntegrinsIBA
11/2001
1Interleukin-2 (IL2)IBA
09/2001
1Interleukin-4 (Interleukin 4)IBA
05/2001
1Interleukin-10 (Interleukin 10)IBA
05/2001
1Interferon-gamma (Interferon, gamma)IBA
05/2001
1HLA-B27 Antigen (HLA B27 Antigen)IBA
12/2000
1C-Reactive ProteinIBA
06/2000
1AutoantigensIBA
06/2000
1Immunoglobulin G (IgG)IBA
05/2000
1Glycoproteins (Glycoprotein)IBA
03/2000
1beta CateninIBA
03/2000
1alpha Catenin (alpha E-Catenin)IBA
03/2000
1gamma Catenin (Plakoglobin)IBA
03/2000
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2000

Therapy/Procedure

2Therapeutics
01/2005 - 01/2001
1Immunomodulation
01/2005
1Activities of Daily Living (ADL)
07/2001
1Intravenous Infusions
06/2000